Ironwood Pharmaceuticals’ Rare Autoimmune Disease Collaboration with COUR Pharmaceuticals

Ropes & Gray represented Ironwood Pharmaceuticals in the collaboration and license option agreement with COUR Pharmaceutical Development Company.The agreement gives Ironwood an option to acquire an…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now